Innate Pharma S.A. logo IPHA - Innate Pharma S.A.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 4
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $6.67 DETAILS
HIGH: $9.00
LOW: $4.00
MEDIAN: $7.00
CONSENSUS: $6.67
UPSIDE: 256.68%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue
Revenue 2.8 12.6 51.9 57.7 12.1 69.8 69.0 79.9 32.6 56.2 17.9 0.9 12.5 10.4 11.7 4.3 7.7 12.9 14.3 6.2 1.3
Cost of Revenue 0 52.0 56.0 51.7 47.0 49.7 45.2 69.6 67 48.6 29.9 12.1 7.6 6.9 1.6 3.4 3.3 2.6 2.8 2.2 0.9
Gross Profit 2.8 12.6 5.6 6.0 (22.3) 20.1 23.8 10.3 (34.4) 7.5 (12) (11.2) 4.9 3.5 10.1 0.9 4.4 10.4 11.5 4.0 0.4
Operating Expenses
R&D Expenses 43.6 52.0 56.0 51.7 47.0 49.7 1.6 69.6 67 48.6 29.9 22.7 15.1 13.4 0 0 0 0 0 0 0
SG&A Expenses 11.0 11.9 11.7 14.5 25.5 19.0 49.6 19.3 16.2 9.3 5.9 12.8 10.7 9.7 9.8 7.1 10.1 0 0 1.8 1.1
Other Expenses 1.6 0.3 (49.5) (2.7) (47.0) (49.7) (0.3) (14.1) (10.6) (9.4) (7.1) (0.0) 0.2 0.0 7.9 0.0 0.9 21.4 20.6 9.3 5.7
Operating Expenses 56.2 64.2 18.3 63.4 25.5 19.0 50.9 74.7 72.6 48.6 28.7 8.8 7.7 6.9 17.7 14.6 19.9 21.4 20.6 11.2 6.8
Operating Income
Operating Income (53.4) (51.6) (12.7) (57.4) (47.8) 1.1 (27.1) 5.1 (40.0) 7.6 (10.8) (20.0) (2.8) (3.4) (7.6) (13.7) (15.5) (11.0) (9.1) (7.2) (6.4)
Interest Expense 0.4 0.6 0.6 0.3 0.3 0.3 0.2 0.1 0.1 0.1 0.1 0 0 0.2 0.5 0.5 0 0.0 0.0 0.0 0
Interest Income 1.3 2.4 3.2 0.5 0.3 0.6 1.8 1.6 1.3 0 0.0 0.4 0.2 0.0 0.9 0.5 0.9 1.2 0.2 1.2 0.3
Profitability
EBITDA (43.6) (46.9) (1.8) (12.3) (43.2) 13.3 (20.9) (3.3) (35.6) 10.8 (8.1) (17.1) (1.9) (1.8) (5.8) (12.3) (14.5) (12.5) (8.5) (6.9) (6.1)
EBIT (48.7) (48.9) (6.9) (57.7) (47.8) 1.1 1.6 5.1 (40.0) 13.1 (6.6) (19.5) (2.7) (3.0) (6.6) (13.1) (15.5) (13.0) (9.1) (6.0) (6.4)
Income Before Tax (49.2) (49.5) (7.6) (58.0) (45.5) (0.8) (20.8) 2.7 (48.0) 12.9 (6.7) (19.6) (2.9) (3.2) (7.0) (13.7) (14.6) (9.9) (8.9) (6.0) (6.1)
Income Tax Expense 0 0 0 0 0 0 0.2 (0.3) 0.4 0.3 0 (0.0) 0 0 0 0 0.0 0 0.1 0 0
Net Income (49.2) (49.5) (7.6) (58.1) (52.8) (64.0) (20.8) 3.0 (48.4) 12.6 (6.7) (19.6) (2.9) (3.2) (7.0) (13.7) (14.6) (9.9) (8.9) (6.0) (6.1)
Per Share Data
EPS (Basic) -0.53 -0.61 -0.09 -0.73 -0.57 -0.01 -0.31 0.05 -0.89 0.23 -0.13 -0.39 -0.07 -0.08 -0.19 -0.36 -0.56 -0.38 -0.36 -0.34 -0.41
EPS (Diluted) -0.53 -0.61 -0.09 -0.73 -0.57 -0.01 -0.31 0.05 -0.89 0.23 -0.13 -0.39 -0.07 -0.08 -0.19 -0.36 -0.56 -0.38 -0.36 -0.34 -0.41
Shares Outstanding 89.4 81.1 84.1 79.6 79.5 78.9 66.9 58.8 54.4 53.9 51.6 50.2 38.7 37.8 37.7 37.4 26.3 25.7 25.1 17.8 14.9
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Current Assets
Cash & Cash Equivalents 28.1 66.4 70.6 84.2 103.8 136.8 202.9 152.3 99.4 175.9 152.9 64.3 38.4 30.6 46.6 31.8 46.4 10.9 2.5 6.2 2.6
Short-Term Investments 6.2 14.4 21.9 17.3 16.1 14.8 16.0 15.2 16.7 21.8 83.0 5.0 3.0 2.0 0 2.8 2.7 22.9 48.3 53.7 15.8
Net Receivables 7.6 1.6 46.5 3.1 1.7 11.3 2.8 146.6 15.1 25.6 9.9 1.0 2.4 2.9 0 5.1 7.1 13.9 2.3 6.9 0
Inventory 0 0 0 0 0 3.3 5.6 0 6.3 0.5 0.3 1.5 0.9 1.2 0 0 0 0 0 0 0
Other Current Assets (0.0) 0 0 27.9 11.8 (0.9) 4.9 0 0 0 0 0 5.2 0 0 0 0.0 3.6 0 0 0
Total Current Assets 46.7 85.7 148.0 139.8 138.3 173.3 237.6 319.6 137.5 230.1 252.1 79.3 49.4 41.0 53.0 40.7 56.3 52.2 55.6 64.3 21.2
Non-Current Assets
Property, Plant & Equipment 4.4 5.1 6.3 8.5 10.2 11.7 11.7 10.2 10.7 9.1 6.3 5.9 6.3 6.8 6.4 7.3 7.9 8.5 1.5 0.8 0.7
Goodwill 0 0 0 (41.0) 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0.4 42.6 44.2 46.3 97.0 84.5 46.2 9.1 9.7 5.4 0 0 0 0 0 0 0 0 0
Long-Term Investments 10.7 10.3 9.8 35.1 39.9 38.9 37.0 35.2 60.5 33.0 37.8 0.1 0.3 0.5 0 0 0 0 0 0 0
Other Non-Current Assets 0.9 9.9 1.6 14.2 30.0 30.1 16.8 0.1 0.1 0.4 37.8 0.1 0.0 0 0.7 0.0 0.0 0.1 6.0 4.2 2.9
Total Non-Current Assets 16.0 25.3 27.2 68.0 129.2 134.1 163.8 131.6 117.5 51.5 53.8 11.4 6.5 7.3 7.1 7.3 8.0 8.7 7.6 5.0 3.6
Total Assets 62.7 111.1 175.2 207.9 267.5 307.4 401.4 451.2 255.0 281.6 306.0 90.7 55.9 48.3 60.1 48.0 64.2 60.9 63.2 69.3 24.8
Current Liabilities
Account Payables 15.0 7.9 8.6 13.7 14.7 20.7 27.9 28.6 20.0 15.6 8.6 6.8 5.1 4.7 4.2 5.0 8.4 6.6 5.1 2.9 2.0
Short-Term Debt 8.5 8.4 8.5 1.3 29.9 1.4 1.5 0.4 0.4 0.4 0.1 0 0.1 0.6 1.7 0.7 0 0 0 0.6 0.2
Deferred Revenue 2.8 0.6 5.9 6.6 12.5 12.5 48.8 82.1 47.9 54.9 (44.4) 0.9 1.3 7.7 0 (0.7) 0 0 0 1.2 0.6
Other Current Liabilities 10.0 7.7 7.8 19.0 21.9 10.1 43.0 71.6 4.7 4.7 10.0 3.5 3.5 9.5 7.4 1.6 0.9 6.2 5.5 6.6 0.1
Total Current Liabilities 36.6 33.0 39.6 41.3 79.9 45.5 121.8 196.7 73.9 76.4 60.2 10.8 9.3 15.4 15.5 7.4 9.3 12.8 10.5 10.0 2.3
Non-Current Liabilities
Long-Term Debt 13.7 22.2 30.6 38.9 11.5 14.2 14.1 2.0 2.4 1.1 1.4 1.5 1.5 0.1 0.8 2.4 7.6 0 0 2.7 0.4
Deferred Tax Liabilities 0 0 9.0 8.6 5.0 7.1 1.3 1.6 3.6 2.6 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 34.0 44.1 39.1 55.7 36.2 49.3 3.9 14.4 3.6 112.3 170.6 1.5 2.1 6.2 13.5 4.7 0.3 6.7 3.0 0.1 2.0
Total Non-Current Liabilities 47.8 69.2 83.7 112.4 80.2 104.8 62.1 87.2 95.2 119.0 173.7 5.3 6.3 9.6 18.0 7.1 7.8 6.7 3.0 2.8 2.4
Total Liabilities 84.4 102.2 132.3 153.7 160.1 151.4 183.9 284.0 169.1 195.4 233.9 16.1 15.6 24.9 33.5 14.5 17.1 19.5 13.5 12.9 4.7
Stockholders' Equity
Common Stock 4.7 4.2 4.0 4.0 4.0 4.0 3.9 3.2 2.9 2.7 2.7 2.6 2.3 1.9 1.9 1.9 1.8 1.3 1.3 1.2 0.7
Retained Earnings (435.4) (386.4) (336.9) (330.3) (272.2) (220.5) (155.7) (134.8) (152.0) (103.6) (116.2) (109.5) (90.0) (87.1) (7.0) (76.9) (63.2) (44.1) (34.5) (26.1) (19.8)
Accumulated Other Comprehensive Income 1.1 0.0 0.5 0.8 0.5 0.4 (0.5) (1.1) 0.2 (0.5) (0.7) (0.2) (0.0) (0.0) 0 0.3 0.2 0 0 0 0
Total Stockholders' Equity (21.7) 8.8 51.9 54.2 107.4 156.0 217.4 167.2 86.0 86.2 72.1 74.6 40.3 23.4 26.6 33.5 47.1 41.3 49.6 56.4 20.1
Total Liabilities & Equity 62.7 111.1 184.2 207.9 267.5 307.4 401.4 451.2 255.0 281.6 306.0 90.7 55.9 48.3 60.1 48.0 64.2 60.9 63.2 69.3 24.8
Debt Metrics
Total Debt 22.6 31.0 39.9 42.3 44.3 19.1 18.7 4.5 5.9 5.3 3.8 4.2 4.8 4.5 13.2 6.8 7.6 0 0 3.3 0.6
Net Debt (5.5) (35.4) (30.7) (42.0) (59.5) (117.7) (184.2) (147.8) (93.5) (170.6) (149.1) (60.1) (33.5) (26.1) (33.4) (25.0) (38.9) (10.9) (2.5) (2.9) (2.0)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Operating Activities
Net Income (7.6) (49.5) (7.6) (58.1) (52.8) (64.0) (20.8) 3.0 (48.4) 12.6 (6.7) (19.6) (2.9) (3.2) (7.0) (13.7) (14.6) (9.9) (8.9) (6.0) (6.1)
Depreciation & Amortization 5.1 2.0 5.1 45.4 4.6 56.8 16.5 7.4 4.4 3.3 2.7 2.3 0.9 0.8 0.9 1.1 1.0 0.5 0.5 0.3 0.3
Stock-Based Compensation 4.3 3.9 4.3 4.2 2.6 2.5 3.8 2.7 9.8 1.0 1.0 0.4 0.3 0 0.2 0.0 1.8 1.3 1.3 1.2 0.2
Change in Working Capital (32.1) 47.7 (32.1) (12.5) (9.9) (49.2) 40.2 (47.1) (17.0) (50.8) 211.5 (1.3) (9.4) (8.6) 19.1 (0.7) 6.8 (7.6) (2.3) 4.9 (1.6)
Other Non-Cash Items (2.2) (11.1) (2.2) 1.8 (1.3) (0.5) (0.8) 0.3 (0.1) (0.4) 0.0 0.2 0.1 0.4 (0.3) (0.0) (1.9) 0.9 0.1 0.0 (1.6)
Operating Cash Flow (32.6) (6.9) (32.6) (19.2) (58.5) (51.8) 34.9 (32.5) (48.1) (36.9) 207.9 (18.1) (11.0) (10.5) 13.0 (13.4) (5.9) (14.7) (9.3) 0.4 (7.2)
Investing Activities
Capital Expenditure (2.4) (0.4) (2.4) (1.1) (1.3) (11.3) (65.4) (1.4) (6.0) (9.4) (7.4) (2.3) (0.4) (1.2) (0.3) (0.4) (0.5) (1.9) (1.3) (0.8) (0.1)
Acquisitions 0 0 0 0 0.0 0.0 0 0.0 3.1 8.0 0 (0.1) (0.1) 0 0 0 0 0.4 0 0 0
Purchases of Investments 0 0 0 0 0 (3) 0 0 (43.3) (18.2) (121.9) (2.0) (3.0) (2.0) 0 0 (0.5) (15.9) 0 (99.4) (5.4)
Sales/Maturities of Investments 22.8 9.6 22.8 3 0 (0.0) 2 25.7 19.8 88.1 7.0 0.5 2.5 0 2.8 0 20 41.5 6.0 61.2 4.0
Other Investing Activities (1.8) 0.0 (1.8) (0.0) 0.4 0.9 1.3 0.0 (3.1) (8.0) 1.0 0.0 0.1 (0.2) 0 0.1 0 (1.5) 0.3 0 0
Investing Cash Flow 20.6 9.2 20.6 1.9 (0.9) (13.4) (62.1) 24.3 (29.5) 60.5 (122.3) (3.8) (1.0) (3.4) 2.4 (0.3) 18.9 22.5 5.0 (39.0) (1.4)
Financing Activities
Net Debt Issuance (2.4) (8.9) (2.4) (2.0) 26.6 (0.9) 11.9 (1.3) 0.5 (0.7) (0.5) (0.6) 0.3 (2.3) (0.7) (0.8) (0.3) 0.6 0.3 0.7 0.2
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 (0.1) 0 0 0 (0.1) (0.3) 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 (0.8) 0 0 0 0 (1.2) 0 0 0 0
Other Financing Activities 0 2.9 0.4 0.2 0.2 (0.3) (0.2) 0.0 0.4 0.1 3.4 1.7 0.3 0 0 0 1.2 0 (0.0) 0.0 0
Financing Cash Flow (2.0) (6.0) (2.0) (1.8) 26.8 (1.1) 77.8 61.2 0.9 (0.6) 3.0 48.0 19.7 (2.1) (0.7) (0.9) 22.6 0.6 0.6 42.2 0.2
Cash Position
Net Change in Cash (13.6) (4.2) (13.6) (19.5) (33.0) (66.1) 50.6 52.9 (76.5) 23.0 88.6 25.9 7.8 (16.0) 14.8 (14.6) 35.6 8.4 (3.7) 3.6 (8.4)
Cash at Beginning 84.2 70.6 84.2 103.8 136.8 202.9 152.3 99.4 175.9 152.9 64.3 38.4 30.6 46.6 31.8 46.4 10.9 2.5 6.2 2.6 11.0
Cash at End 70.6 66.4 70.6 84.2 103.8 136.8 202.9 152.3 99.4 175.9 152.9 64.3 38.4 30.6 46.6 31.8 46.4 10.9 2.5 6.2 2.6
Free Cash Flow (34.9) (7.3) (34.9) (20.3) (59.8) (63.1) (30.5) (34.0) (54.1) (46.2) 200.5 (20.5) (11.4) (11.7) 12.7 (13.9) (6.4) (16.6) (10.6) (0.4) (7.4)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Income Statement
Revenue 2.8 12.6 51.9 57.7 12.1 69.8 69.0 79.9 32.6 56.2 17.9 0.9 12.5 10.4 11.7 4.3 7.7 12.9 14.3 6.2 1.3
Gross Profit 2.8 12.6 5.6 6.0 (22.3) 20.1 23.8 10.3 (34.4) 7.5 (12) (11.2) 4.9 3.5 10.1 0.9 4.4 10.4 11.5 4.0 0.4
Operating Income (53.4) (51.6) (12.7) (57.4) (47.8) 1.1 (27.1) 5.1 (40.0) 7.6 (10.8) (20.0) (2.8) (3.4) (7.6) (13.7) (15.5) (11.0) (9.1) (7.2) (6.4)
Net Income (49.2) (49.5) (7.6) (58.1) (52.8) (64.0) (20.8) 3.0 (48.4) 12.6 (6.7) (19.6) (2.9) (3.2) (7.0) (13.7) (14.6) (9.9) (8.9) (6.0) (6.1)
EPS (Diluted) -0.53 -0.61 -0.09 -0.73 -0.57 -0.01 -0.31 0.05 -0.89 0.23 -0.13 -0.39 -0.07 -0.08 -0.19 -0.36 -0.56 -0.38 -0.36 -0.34 -0.41
Balance Sheet
Cash & Equivalents 28.1 66.4 70.6 84.2 103.8 136.8 202.9 152.3 99.4 175.9 152.9 64.3 38.4 30.6 46.6 31.8 46.4 10.9 2.5 6.2 2.6
Total Assets 62.7 111.1 175.2 207.9 267.5 307.4 401.4 451.2 255.0 281.6 306.0 90.7 55.9 48.3 60.1 48.0 64.2 60.9 63.2 69.3 24.8
Total Debt 22.6 31.0 39.9 42.3 44.3 19.1 18.7 4.5 5.9 5.3 3.8 4.2 4.8 4.5 13.2 6.8 7.6 0 0 3.3 0.6
Stockholders' Equity (21.7) 8.8 51.9 54.2 107.4 156.0 217.4 167.2 86.0 86.2 72.1 74.6 40.3 23.4 26.6 33.5 47.1 41.3 49.6 56.4 20.1
Cash Flow
Operating Cash Flow (32.6) (6.9) (32.6) (19.2) (58.5) (51.8) 34.9 (32.5) (48.1) (36.9) 207.9 (18.1) (11.0) (10.5) 13.0 (13.4) (5.9) (14.7) (9.3) 0.4 (7.2)
Capital Expenditure (2.4) (0.4) (2.4) (1.1) (1.3) (11.3) (65.4) (1.4) (6.0) (9.4) (7.4) (2.3) (0.4) (1.2) (0.3) (0.4) (0.5) (1.9) (1.3) (0.8) (0.1)
Free Cash Flow (34.9) (7.3) (34.9) (20.3) (59.8) (63.1) (30.5) (34.0) (54.1) (46.2) 200.5 (20.5) (11.4) (11.7) 12.7 (13.9) (6.4) (16.6) (10.6) (0.4) (7.4)